To include your compound in the COVID-19 Resource Center, submit it here.

Theratope fails breast cancer Phase III

Biomira (TSE:BRA; BIOM) was off $2.51 (63%) to $1.49 on 26.8 million shares on

Read the full 144 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE